Fig. 3From: Update of a prognostic survival model in head and neck squamous cell carcinoma patients treated with immune checkpoint inhibitors using an expansion cohortImpact of Lymphocyte (3A) and Neutrophil (3B) counts on Overall SurvivalBack to article page